Obstructive sleep apnea successfully treated by mandibular distraction osteogenesis in a rare skeletal dysplasia

Amanda Louise Griffiths1, Andrew Heggie, Sarah Holman

  • 1Department of Respiratory Medicine, Royal Children's Hospital, Melbourne, Australia. mandie.griffiths@rch.org.au

Insights

Osteopathia striata with cranial sclerosis (OSCS) is a rare skeletal dysplasia. This report details a female infant with OSCS successfully treated for severe sleep apnea using mandibular distraction osteogenesis.

Area of Science:

  • Genetics
  • Skeletal Dysplasias
  • Pediatric Medicine

Background:

  • Osteopathia striata with cranial sclerosis (OSCS) is a rare X-linked skeletal dysplasia.
  • It is characterized by bone abnormalities and extraskeletal anomalies.
  • OSCS can present with features of Pierre Robin sequence.

Purpose of the Study:

  • To report a case of OSCS in a female infant.
  • To describe the successful management of severe obstructive sleep apnea in this patient.
  • To highlight a novel treatment approach for OSCS-related complications.

Main Methods:

  • Radiographic diagnosis of OSCS in an infant.
  • Molecular confirmation of the genetic diagnosis.
  • Surgical intervention with mandibular distraction osteogenesis for sleep apnea.

Main Results:

  • The patient was diagnosed with OSCS in her first year of life.
  • Severe obstructive sleep apnea was effectively treated with mandibular distraction osteogenesis.
  • This represents the first reported use of this procedure for OSCS.

Conclusions:

  • Mandibular distraction osteogenesis is a viable treatment for severe obstructive sleep apnea in infants with OSCS.
  • Early diagnosis and intervention are crucial for managing OSCS-related complications.
  • This case expands the understanding of OSCS management.